Clinical Trials

Bristol Myers Squibb has entered a global agreement with Evinova to deploy AI-powered clinical development tools across its worldwide pipeline. The Bristol Myers Evinova partnership is designed to improve trial efficiency, reduce costs and support better decision-making throughout drug...

Roche announced late-breaking Phase III data showing that fenebrutinib reduces disability progression in PPMS, marking the first investigational advance for primary progressive multiple sclerosis in more than a decade. Results from the FENtrepid study showed the Bruton’s tyrosine kinase...

Deep dive into the physiological and biochemical obstacles that hinder the oral administration of biologics and large molecules, and the innovations designed to overcome them.

Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.

An exploration of how advanced dosing mechanisms maintain therapeutic stability, reduce side effects, and improve patient compliance in the management of chronic conditions.

Exploration of how sophisticated delivery mechanisms enhance medical efficacy, reduce side effects, and enable personalized treatment across oncology, neurology, and chronic disease management.

GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials, assessing bepirovirsen, which is an investigational antisense oligonucleotide - ASO used for the treatment of...